In selenium therapy, this could involve adjusting Se dosages based on the patients genetic makeup, which influences how they metabolize and respond to Se
Take our free assessment quiz today to explore your options and start your personalized journey
Almost all are administered subcutaneously, although oral semaglutide is currently available in Spain (see below)
Microdosing GLP-1 $99 for 30-day supply LIMITED TIME: Save up to $100 Microdosing GLP-1 (Injectable) for Longevity $99 for 30-day supply Microdosing GLP-1 is designed to work in sync with your body which may minimize side effects, promote long-term wellness, and support moderate weight loss
Current treatments offer meaningful benefits while awaiting new options Experience with existing medications provides useful insights for future treatment Addressing underlying health conditions improves outcomes with any intervention Lifestyle modifications enhance and sustain pharmaceutical treatment effects Building healthy habits now prepares you for optimal future results Key Takeaways Retatrutide is a novel triple-agonist medication targeting GLP-1, GIP, and glucagon receptors simultaneously for comprehensive weight management Phase 2 clinical trials demonstrated up to 24% weight loss, potentially exceeding results seen with current market-leading medications like Mounjaro and Wegovy The glucagon receptor component may increase energy expenditure and fat burning, addressing both sides of the energy balance equation UK availability is expected around 2026-2027 following completion of Phase 3 trials and regulatory approval processes While waiting for Retatrutide, optimising current treatments and establishing healthy lifestyle foundations prepares you for future options When to Seek Professional Advice Navigating the evolving landscape of weight loss treatments can feel overwhelming, and professional guidance is invaluable for making informed decisions about your health
